Man Group
TXG icon

Man Group’s 10x Genomics TXG Stock Holding History

Man Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.72M Sell
269,264
-123,800
-31% -$2.47M 0.01% 1086
2025
Q4 		$6.41M Sell
393,064
-201,478
-34% -$3.04M 0.01% 987
2025
Q3 		$6.95M Sell
594,542
-235,068
-28% -$3.06M 0.01% 952
2025
Q2 		$9.61M Buy
829,610
+687,773
+485% +$6.27M 0.02% 794
2025
Q1 		$1.24M Buy
141,837
+15,171
+12% +$191K ﹤0.01% 1521
2024
Q4 		$1.82M Buy
126,666
+55,346
+78% +$873K ﹤0.01% 1337
2024
Q3 		$1.61M Sell
71,320
-35,306
-33% -$730K ﹤0.01% 1377
2024
Q2 		$2.07M Buy
106,626
+62,061
+139% +$1.63M 0.01% 1328
2024
Q1 		$1.67M Sell
44,565
-182,602
-80% -$8.02M ﹤0.01% 1373
2023
Q4 		$12.7M Buy
+227,167
New +$9.88M 0.04% 549
2023
Q3 		– Sell
-195,810
Closed -$10.2M – 442
2023
Q2 		$10.9M Buy
+195,810
New +$10.6M 0.03% 595
2023
Q1 		– Sell
-543,006
Closed -$25.4M – 501
2022
Q4 		$19.8M Buy
+543,006
New +$17.8M 0.07% 344
2022
Q1 		– Sell
-3,085
Closed -$459K – 2373
2021
Q4 		$459K Sell
3,085
-49,009
-94% -$7.51M ﹤0.01% 1560
2021
Q3 		$7.58M Buy
52,094
+25,215
+94% +$4.33M 0.03% 676
2021
Q2 		$5.26M Sell
26,879
-25,814
-49% -$4.67M 0.02% 862
2021
Q1 		$9.54M Sell
52,693
-5,924
-10% -$1.02M 0.04% 449
2020
Q4 		$8.3M Buy
58,617
+2,784
+5% +$404K 0.04% 521
2020
Q3 		$6.96M Sell
55,833
-7,702
-12% -$808K 0.03% 645
2020
Q2 		$5.67M Buy
+63,535
New +$4.95M 0.03% 606

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's TXG Position: Q1 2026 in Review

Man Group reduced its 10x Genomics (TXG) stake by 31% in Q1 2026, selling an estimated $2.47M and leaving 269,264 shares worth $5.72M. The position accounts for 0.01% of the portfolio, ranked #1086.

Man Group first reported a position in TXG in Q2 2020 and has held it in 19 quarters since. The position peaked at $19.8M in Q4 2022. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Man Group held 269,264 shares of 10x Genomics worth $5.72M as of Q1 2026.
  • Man Group sold 123,800 10x Genomics shares in Q1 2026, an estimated $2.47M.
  • 10x Genomics made up 0.01% of Man Group's portfolio in Q1 2026, its #1086 holding.
  • Man Group first reported a position in 10x Genomics in Q2 2020 and has held it in 19 quarters since.
  • Man Group's 10x Genomics position peaked at $19.8M in Q4 2022.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.